Patents

Patent EP3512835, a A Process For Purification of Carfilzomib Intermediate.

Patent US10253066, A Process For Purification of Carfilzomib.

Patent US9688625, AMORPHOUS FORM OF A THIOCOLCHICINE DERIVATIVE.

Patent US10414829, An Improved Process For The Preparation of Sugammadex And Its Intermediates.

Patent US10414830, Crystalline Forms Of Per-chloro-gamma-cyclodextrines.

Patent US 08771642, Active particles for bio-analytical applications and methods for their preparation.

Patent US 8735475 B2, Inhibitor combination, resin mixture containing same and use of same.

Patent PCT/IB2014/061230, Method for controlling solubility of quantum dots.

Patent WO2015007706A1, Fluoropolymer fibre.

Patent WO 2014207655, Method for producing, from a polymer matrix in a liquid phase, a solid material containing nano-additives.

Patent US9586919, A CRYSTALLINE ANHYDROUS FORM OF CABAZITAXEL, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF.

Patent US9163034, CRYSTALLINE (6R,7R)-7-{2-(5-AMIN0-[1 ,2,4] THIADIAZOL-3-YL)-2-[(Z)­ TRITYLOXYIMINO]-ACETYLAMINO }-3- [(R)-l'-TERT-BUTOXYCARBONYL-2-0XO­ [1,3']BIPYRROLIDINYL-(3E)­ YLIDENEMETHYL ]-8-0X0-5-THIA-1 -AZA­ BICYCL0[4.2.0]0CT-2-ENE-2-CARBOXYLIC ACID BENZHYDRYL ESTER; ITS MANUFACTURE AND USE.

Patent U.S. provisional patent application Serial No. 61/754,793, DEVICE AND METHOD FOR SUBJECTING A LIQUID TO PLASMA TREATMENT.

Patent 61.U2164.12.IT.37, DISPOSITIVO E METODO DI GENERAZIONE DI PLASMA FREDDO.

Patent RM2013A000269, Method for controlling solubility of quantum dots.

Patent BO2013A000444, DISPOSITIVO E METODO DI GENERAZIONE DI SPECIE REATTIVE MEDIANTE PLASMA A PRESSIONE ATMOSFERICA.

Patent BO2013A000334, METODO PER LA REALIZZAZIONE DI UN MATERIALE SOLIDO NANOADDITIVATO A PARTIRE DA UNA MATRICE POLIMERICA IN FASE LIQUIDA.

Patent U.S. provisional patent application Serial No. 61/750,995, DEVICE FOR GENERATING A COLD PLASMA FLOW AT ATMOSPHERIC PRESSURE.

Patent WO2014024106 (A1), METHOD FOR THE PRODUCTION OF THERMOCHEMILUMINESCENT SILICA NANOPARTICLES AND THEIR USE AS MARKERS IN BIOANALYTIC METHODS.

Patent WO2015058960, Crystalline solvate forms of cabazitaxel.